China (Mainland)
Carbonic acid 4-nitrophenyl 5-thiazolylmethyl ester CAS NO.144163-97-3
- Min.Order: 10 Gram
- Payment Terms: T/T,Other
- Product Details
Keywords
- Carbonic acid 4-nitrophenyl 5-thiazolylmethyl ester
- 5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate supplier
- 144163-97-3
Quick Details
- ProName: Carbonic acid 4-nitrophenyl 5-thiazoly...
- CasNo: 144163-97-3
- Molecular Formula: C11H8N2O5S
- Appearance: white powder
- Application: APIs, pharmaceutical intermediates
- DeliveryTime: within 1-10 working days
- PackAge: Aluminous bag or plastic bags
- Port: Shanghai or Any China port
- ProductionCapacity: 1000 Kilogram/Day
- Purity: 99%
- Storage: Store in dry,dark,ventilated place
- Transportation: By Sea or By Air
- LimitNum: 10 Gram
Superiority
Shanghai LONGBANG , Boasts strong competitive advantages by our well-trained chemists with rich professional backgroud. We aim to win the market via quick response and fast delivery, as well as continous development for high-tech medical compounds, bio-medicine, and new pharmaceutical intermediates.
- Our quality assurance system is based on GMP.
- Products are exported to all over the world: USA, Europe, South Asia, Middle East and so on, also has established long term and stable business relationships with our customers.
- Fast delivery
- High quality, Preferential price
Details
5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate Purity: 99% CAS No.: 144163-97-3 Grade: Pharmceutical Grade Lead Time: 1-2 days upon receipt of payment Delivery Time: Usually 4-6 working days by air Storage: Refrigerator Usage: API, intermediate for Ritonavir, one kind of anti-AIDS drug Product description: MF: C11H8N2O5S MW: 280.26 Assay ≥ 99.0% Appearance: Pale-Yellow Solid Moisture: ≤ 0.5% Melting point: 126-127 ° C Boiling point: 475.333 ° C at 760 mmHg Refractive index: 1.627 Density: 1.485 About Ritonavir: Ritonavir, is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. Ritonavir is frequently prescribed with HAART, not for its antiviral action, but as it inhibits the same host enzyme that metabolizes other protease inhibitors. This inhibition leads to higher plasma concentrations of these latter drugs, allowing the clinician to lower their dose and frequency and improving their clinical efficacy.
Email: maggie@longbangsy.com
